8-KLeadership ChangesExhibits & Filings

TransDigm Group INC 8-K Report, Executive Changes (Jul 1, 2021)

Filed July 1, 2021For Securities:TDG

Summary

TransDigm Group Incorporated (TDG) announced a change to its Board of Directors through an 8-K filing on June 30, 2021. The Board's size was expanded to 12 members with the election of Jane M. Cronin, who brings significant experience as Senior Vice President and Corporate Controller at Sherwin Williams. Ms. Cronin's appointment is notable for her expertise in accounting and her experience with acquisition integration, both valuable attributes for a company like TransDigm. Her independence and lack of related-party transactions further strengthen the Board's governance. Investors should view this as a strategic addition aimed at enhancing oversight and expertise, particularly in financial and operational integration aspects relevant to TransDigm's business.

Key Highlights

  • 1TransDigm Group expanded its Board of Directors from 11 to 12 members.
  • 2Jane M. Cronin was elected as a new director.
  • 3Ms. Cronin brings 20+ years of experience, currently serving as Senior Vice President and Corporate Controller at Sherwin Williams.
  • 4Her qualifications include extensive accounting knowledge and experience with acquisition integration.
  • 5Ms. Cronin meets independence requirements set by the NYSE and SEC.
  • 6There are no disclosed related-party transactions or specific arrangements influencing her appointment.
  • 7Ms. Cronin will be compensated according to the company's standard director compensation policy.

Frequently Asked Questions

TransDigm expanded its Board to accommodate the addition of a new director, Jane M. Cronin, to leverage her specific expertise in accounting and acquisition integration.

Jane M. Cronin is currently the Senior Vice President and Corporate Controller at Sherwin Williams. Her experience as a senior accounting officer in a large manufacturing company, along with her background in acquisition integration, is highly relevant to TransDigm's operations and strategic growth.

Yes, Ms. Cronin is deemed independent under the listing standards of the New York Stock Exchange and the rules and regulations of the Securities and Exchange Commission.

Based on the filing, there are no disclosed transactions with the Company that require disclosure under Item 404(a) of Regulation S-K, nor are there any specific arrangements or understandings influencing her selection, suggesting no apparent conflicts of interest.